Medical Advocates
Zidovudine/Lamivudine (Combivir)
 
Main Page

New and Noteworthy
Database of ARV Drug Interactions
Combivir PI
Journal Data
 Conference Data
 Pediatric Data
 Perinatal Data


 
ZDV Main Page Main New/Newsworthy  Home Page      
Last updated:  July 06, 2015
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
     
June 2014
 
Drug Alerts
 
Pediatric Data
       
USPHS Pediatric Antiretroviral Drug Information

 US Treatment Guidelines
 
Efficacy
 
ZDV/3TC
 
    Journal Papers, Abstracts, and Commentaries
 
  Development of fixed dose combination tablets containing zidovudine and lamivudine
for paediatric applications.
Kayitare E, Vervaet C, Ntawukulilyayo JD,
Int J Pharm. 2008 Nov 18.
Abstract
 
ZDV/3TC/NVP
 
    Journal Papers, Abstracts, and Commentaries
 
  Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine
 in HIV-infected children.
Chokephaibulkit K, Cressey TR, Capparelli E, et al
Antivir Ther. 2011;16(8):1287-1295.
 Abstract
 
      Conference Reports, Abstracts, and Posters
 
  POSTER
The pediatric dispersible tablet with a FDC of 3TC/NVP/AZT is bioequivalent to the combination of Retrovir® syrup, Epivir® solution and Viramune® suspension providing simplified adaptable dosing for pediatric patients
T Bhushan, A. Deshmukh, S. Chakraborty, et al
(7th IAS Conference)
Poster      Abstract(

ZDV/3TC vs DDI

    Journal Papers, Abstracts, and Commentaries

  A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy
in children with symptomatic therapy-naïve HIV-1 infection.
The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team.
McKinney RE,Johnson GM, Stanley K et al.
Journal of Pediatrics 1998; 133(4): 500-508.
Abstract
   
  Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected
children.
AIDS Clinical Trials Group (ACTG) Study 152 Team. 
Englund JA, Baker CJ, Raskino C et al.
New England Journal of Medicine 1997; 336(24): 1704-1712.
Abstract

ZDV/3TC/ABC vs ZDV/ 3TC

     Journal Papers, Abstracts, and Commentaries

  A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine,
and zidovudine versus lamivudine and zidovudine in previously treated human
immunodeficiency virus type 1-infected children.
Saez-Llorens X, Nelson RP, Emmanuel P et al
Pediatrics. 2001 Jan;107(1):E4.
Abstract

 

'  

ZDV Main Page Main New/Newsworthy  Home Page      

Combivir Main Page